We present a descriptive analysis utilizing pharmacy claims from a managed care population to quantify adherence, persistence, and switching patterns for patients initiating dabigatran.
Brian K. Solow, MD
Advertisement
Articles by Brian K. Solow, MD
Improving Patient Self-Management of Multiple Sclerosis Through a Disease Therapy Management Program
This study evaluated the effect of a multiple sclerosis disease therapy management program on medication adherence, therapy persistence, relapses, work productivity, and quality of life.
Advertisement
Latest Updated Articles
- Improving Patient Self-Management of Multiple Sclerosis Through a Disease Therapy Management Program
Published: February 5th 2010 | Updated:
- Adherence, Persistence, and Switching Patterns of Dabigatran Etexilate
Published: September 16th 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Revumenib Granted FDA Approval for R/R NPM1-Mutated AML
4
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
5
